CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...